Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8VCL

Crystal structure of HLA-A*03:01 in complex with a mutant PIK3CA peptide

Summary for 8VCL
Entry DOI10.2210/pdb8vcl/pdb
DescriptorHLA class I histocompatibility antigen, A alpha chain, Beta-2-microglobulin, Mutant PIK3CA peptide, ... (6 entities in total)
Functional Keywordspeptide-class i major histocompatibility complex, pmhc, immune system
Biological sourceHomo sapiens (human)
More
Total number of polymer chains3
Total formula weight44756.49
Authors
Ma, J.,Baker, B.M. (deposition date: 2023-12-14, release date: 2024-12-11, Last modification date: 2025-07-09)
Primary citationMa, J.,Ayres, C.M.,Brambley, C.A.,Chandran, S.S.,Rosales, T.J.,Perera, W.W.J.G.,Eldaly, B.,Murray, W.T.,Corcelli, S.A.,Kovrigin, E.L.,Klebanoff, C.A.,Baker, B.M.
Dynamic allostery in the peptide/MHC complex enables TCR neoantigen selectivity.
Nat Commun, 16:849-849, 2025
Cited by
PubMed Abstract: The inherent antigen cross-reactivity of the T cell receptor (TCR) is balanced by high specificity. Surprisingly, TCR specificity often manifests in ways not easily interpreted from static structures. Here we show that TCR discrimination between an HLA-A*03:01 (HLA-A3)-restricted public neoantigen and its wild-type (WT) counterpart emerges from distinct motions within the HLA-A3 peptide binding groove that vary with the identity of the peptide's first primary anchor. These motions create a dynamic gate that, in the presence of the WT peptide, impedes a large conformational change required for TCR binding. The neoantigen is insusceptible to this limiting dynamic, and, with the gate open, upon TCR binding the central tryptophan can transit underneath the peptide backbone to the opposing side of the HLA-A3 peptide binding groove. Our findings thus reveal a novel mechanism driving TCR specificity for a cancer neoantigen that is rooted in the dynamic and allosteric nature of peptide/MHC-I binding grooves, with implications for resolving long-standing and often confounding questions about T cell specificity.
PubMed: 39833157
DOI: 10.1038/s41467-025-56004-8
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.4 Å)
Structure validation

238895

PDB entries from 2025-07-16

PDB statisticsPDBj update infoContact PDBjnumon